Chen HY, Lin YH, Wu JC, Hu S, Yang SH, Chen JL, et al. Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: a 1-year follow-up cohort study. J Ethnopharmacol 2015;159:189–196.

Zhang CS, Yu JJ, Parker S, Zhang AL, May B, Lu C, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol 2014;53:1305–1318.

Li S, Kuchta K, Tamaru N, Lin Y, Iwasaki S, Wang R, et al. Efficacy of a novel herbal multicomponent traditional Chinese medicine therapy approach in patients with atopic dermatitis. Forsch Komplementmed 2013;20:189–196.

Smith N, Shin DB, Brauer JA, Mao J, Gelfand JM. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol 2009;60:419–425.

Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1–191.

Gu S, Yang AW, Li CG, Lu C, Xue CC. Topical application of Chinese herbal medicine for atopic eczema: a systematic review with a meta-analysis. Dermatology 2014;228:294–302.

Gu S, Yang AW, Xue CC, Li CG, Pang C, Zhang W, et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 2013;9:CD008642.

Perharic L, Shaw D, Leon C, De Smet PA, Murray VS. Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Vet Hum Toxicol 1995;37:562–566.

Oh SJ, Cho JH, Son CG. Systematic review of the incidence of herbal drug-induced liver injury in Korea. J Ethnopharmacol 2015;159:253–256.

Sheehan MP, Rustin MH, Atherton DJ, Buckley C, Harris DW, Brostoff J, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13–17.

Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;126:179–184.

Mao H, Mao YH. Clinical observation of integration of Chinese medicine and Western medicine treatment for psoriasis vulgaris. China Health Innov (Chin) 2007;19:64.

Kong HY. Clinical observation of integration of traditional and Western medicine for psoriasis. Inner Mongolia J Tradit Chin Med (Chin) 2007;3:22–23.

Teelucksingh S, Mackie ADR, Burt D, McIntyre MA. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990;335:1060–1063.

Kageyama Y, Suzuki H, Saruta T. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney. J Endocrinol 1992;135:147–152.

Soma R, Ikeda M, Morise T, Miyamori I, Takeda R. Effect of glycyrrhizin on cortisol metabolism in humans. Endocr Regul 1994;28:31–34.

Krähenbühl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab 1994;78:581–585.

Chen MF, Shimada F, Kato H, Yano S, Kanaoka M. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Endocrinol Jpn 1990;37:331–341.

Chen MF, Shimada F, Kato H, Yano S, Kanaoka M. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol Jpn 1991;38:167–174.

Ojima M, Satoh K, Gomibuchi T, Itoh N, Kin S, Fukuchi S, et al. The inhibitory effects of glycyrrhizin and glycyrrhetinic acid on the metabolism of cortisol and prednisolone—in vivo and in vitro studies. Folia Endocrinol Jap 1990;66:584–596.

Homma M, Oka K, Ikeshima K, Takahashi N, Niitsuma T, Fukuda T, et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995;47:687–692.

Frey BM, Seeberger M, Frey FJ. Pharmacokinetics of 3 prednisolone prodrugs: evidence of therapeutic inequivalence in renal transplant patients with rejection. Transplantation 1985;39:270–274.

Kuhn MA. Herbal remedies: drug-herb interactions. Crit Care Nurse 2002;22:22–35.

Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J. A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-β-hydroxysteroid dehydrogenase activity by glycyrrhetic acid. Toxicol Appl Pharmacol 2001;170:46–55.

Makino T, Ohtake N, Watanabe A, Tsuchiya N, Imamura S, Iizuka S, et al. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury. Drug Metab Dispos 2008;36:1438–1443.

Brooks SM, Sholiton LJ, Werk EE Jr, Altenau P. The effects of ephedrine and theophylline on dexamethasone metabolism in bronchial asthma. J Clin Pharmacol 1977;176:308–318.